Suppr超能文献

普萘洛尔和5-单硝酸异山梨酯对肝硬化门静脉血流和内脏动脉循环影响的双功多普勒评估

Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.

作者信息

Piscaglia F, Gaiani S, Siringo S, Gramantieri L, Serra C, Bolondi L

机构信息

Department of Internal Medicine and Gastroenterology, University of Bologna, Italy.

出版信息

Aliment Pharmacol Ther. 1998 May;12(5):475-81. doi: 10.1046/j.1365-2036.1998.00333.x.

Abstract

BACKGROUND

A decrease in portal flow is an important pharmacological effect of drugs used for the prophylaxis of variceal bleeding.

AIM

To assess the acute and chronic effects of propranolol, and the effect of the acute addition of isosorbide-5-mononitrate, on splanchnic circulation.

METHODS

Measurements of portal blood flow volume (PBFV) and of Doppler ultrasound pulsatility index of the superior mesenteric, femoral and interlobar renal arteries were performed in 10 cirrhotic patients with varices at baseline, 90 min after propranolol or placebo, after 30 days of chronic propranolol treatment and 45 min after the addition of isosorbide-5-mononitrate.

RESULTS

The mean PBFV was significantly lower at all times than at baseline, with the greatest mean percentage decrease achieved after the addition of isosorbide-5-mononitrate (> or = 20% in all patients). Acute changes, however, did not predict the chronic effects in many patients. Isosorbide-5-mononitrate significantly increased the mesenteric and femoral pulsatility indices, whereas no significant change was observed in the kidney.

CONCLUSIONS

Propranolol significantly decreases PBFV, but chronic effects cannot be reliably predicted by the acute change. All patients achieved a decrease in PBFV of > or = 20% after the acute addition of isosorbide-5-mononitrate to chronic propranolol treatment.

摘要

背景

门静脉血流减少是用于预防静脉曲张出血药物的一项重要药理作用。

目的

评估普萘洛尔的急性和慢性效应,以及急性加用5-单硝酸异山梨酯对内脏循环的影响。

方法

对10例患有静脉曲张的肝硬化患者在基线时、服用普萘洛尔或安慰剂90分钟后、慢性普萘洛尔治疗30天后以及加用5-单硝酸异山梨酯45分钟后,测量门静脉血流量(PBFV)以及肠系膜上动脉、股动脉和肾叶间动脉的多普勒超声搏动指数。

结果

所有时间点的平均PBFV均显著低于基线,加用5-单硝酸异山梨酯后平均下降百分比最大(所有患者均≥20%)。然而,在许多患者中急性变化并不能预测慢性效应。5-单硝酸异山梨酯显著增加肠系膜和股动脉搏动指数,而肾脏未观察到显著变化。

结论

普萘洛尔显著降低PBFV,但急性变化不能可靠地预测慢性效应。在慢性普萘洛尔治疗基础上急性加用5-单硝酸异山梨酯后,所有患者的PBFV均下降≥20%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验